Keyphrases
APOBEC3A
100%
APOBEC3
70%
Mutagenesis
41%
Replication Stress
34%
In Cancer
34%
Chromosome 5
33%
Structural Maintenance of Chromosomes
33%
Genotoxicity
33%
Hematological Malignancies
33%
Malignancy
29%
DNA Damage Response
28%
Cytidine Deaminase
27%
Pediatric Patients
20%
DNA Damage Signaling
19%
Human Cancer
17%
Deamination
16%
DNA Damage
16%
Genomic Instability
16%
DNA Breaks
15%
Viral Infection
15%
Infections in children
14%
Double-strand Breaks
14%
Cytosine Deaminase
14%
DNA Replication
14%
Immunocompromised Pediatric Patients
13%
Neurofibromatosis Type 1 (NF-1)
13%
Neurofibromatosis Type I
13%
B Cells
13%
Etiology
13%
Children with Cancer
12%
Infection Risk
12%
Cancer Therapy
12%
DNA Damage Checkpoint
12%
Physiologic
12%
Single-stranded DNA (ssDNA)
12%
Synthetic Lethality
12%
Acute Myeloid Leukemia
12%
Therapeutic Vulnerabilities
11%
Cancer Genome
11%
Pediatric Cancer
11%
Antineoplastic Drugs
11%
Aging
11%
Vascular Anomalies
11%
Sirolimus
11%
Base Editor
11%
Allogeneic Hematopoietic Cell
11%
Anti-HBc
11%
Pediatric Cancer Patients
11%
Curvularia
11%
Chaperonin
11%
Biochemistry, Genetics and Molecular Biology
Enzyme
55%
Mutagenesis
45%
DNA Synthesis
42%
Chromosome 5
33%
Deamination
33%
DNA Damage Response
32%
Cytidine Deaminase
30%
Cytosine Deaminase
30%
Genome Instability
22%
DNA Damage
21%
Cancer Cell
21%
Drive
16%
Synthetic Lethality
16%
Single-Stranded DNA
15%
Cytidine
14%
Nucleic Acid Base Substitution
11%
RAG1
11%
Genome Editing
11%
Quantitative Technique
11%
Small Molecule
11%
Curvularia
11%
Carcinogenesis
11%
B Cell
11%
Cytotoxicity
11%
Nuclease
11%
Chaperonin
11%
Anticancer
11%
Mesenchymal-Epithelial Transition
11%
Poly ADP Ribose Polymerase
11%
APOBEC
9%
Cell Cycle Arrest
7%
Innate Immunity
7%
Cell Cycle Checkpoint
7%
Gene Rearrangement
7%
Somatic Mutation
7%
Kinase
6%
Phosphotransferase
6%
DNA Damage Checkpoint
5%
Solution and Solubility
5%
Mutagenic Activity
5%
Cell Death
5%
Mould
5%
Cell Damage
5%
Programmed Cell Death
5%
Intravenous Immunoglobulin
5%
Endonuclease
5%
Medicine and Dentistry
Malignant Neoplasm
42%
Infection
35%
Hematologic Malignancy
33%
Cancer
31%
Pediatrics Patient
30%
Diseases
19%
Pediatric Cancer
18%
Drive
17%
DNA Damage Response
16%
Metastatic Carcinoma
14%
Neurofibromatosis Type I
13%
Mutagenesis
12%
Cancer Cell
12%
Pediatrics
11%
Vascular Anomaly
11%
Glycosylation
11%
Systematic Review
11%
Chimeric Antigen Receptor T-Cell
11%
Sickle-Cell Disease
11%
Hepatitis B Core Antibody
11%
Rapamycin
11%
Infarction
11%
Osteomyelitis
11%
Human Adenovirus Infection
11%
Fungal Infection
11%
Magnetic Resonance Imaging
11%
Infectious Complication
11%
Immunoassay
11%
Stem Cell Transplant
11%
Antivirus Agent
11%
Mycosis
11%
Clinical Study
11%
Polyethylene Terephthalate
11%
Chronic Myelogenous Leukemia
11%
Ovarian Cancer
11%
Mesenchymal-Epithelial Transition
11%
Cytosine Deaminase
11%
Peptidase
8%
Signal Peptide
8%
Juvenile Myelomonocytic Leukemia
8%
Immunoglobulin
7%
Neoplasm
7%
Leukemia
7%
Genomic Instability
7%
Gene Rearrangement
7%
Positron Emission Tomography
6%
Tumor
6%
Acute Myeloid Leukemia
6%
Acute Lymphoblastic Leukemia
6%
Human Adenovirus C
6%